Pentax 2009 Annual Report Download - page 23

The EPK-i endoscope system
The EPK-i endoscope system
combines the high-resolution
EPK-i video processor and the
90i video scope equipped with
a megapixel CCD. Thanks to
high-definition imaging and the
proprietary i-scan image pro-
cessing function, the system
supports advanced endoscopic
testing and diagnosis.
EG-2790i scope
This high-grade scope achieves
dramatically high resolution
through use of a high-definition
CCD, and with a diameter of
9.0mm is ultra-light and slim
enough for routine testing.
In the Lifecare Business, we provide clinicians with high-resolution,
high-usability endoscopes and new ceramics products for medical
use, contributing to the enhancement of both medical care and
patient QOL (Quality of Life).
ENDOSCOPES FOR MEDICAL USE
Fiscal 2009 Business Overview and Results
In the medical devices field, Pentax develops high-quality flexible
endoscopes for medical use and medical accessories (surgical
instruments for endoscopes), primarily for the gastrointestinal
system and sells them in Japan, North America, and in European
countries. Because flexible endoscopes are inserted into narrow
and convoluted luminal spaces, they must have superb operability
to enable doctors to achieve precise manipulation, as well as high-
resolution image processing to allow doctors to determine which
areas are affected by cancer or other diseases. Pentax utilizes its
many years of experience in optomechatronic technology to
achieve these capabilities.
Endoscopes enable diagnosis and treatment without placing a
heavy burden on patients’ bodies, and help keep down healthcare
costs by facilitating early detection and treatment of various condi-
tions. For this reason, these tools are being actively introduced as a
minimally invasive method of treatment at medical institutions
across the globe.
In the fiscal year under review, sales of the EPK-i series of endo-
scopes with megapixel-level resolution continued to post robust
growth in the European and North American markets. In May 2008,
the series was also launched in Japan, where it made a strong start,
earning kudos from physicians for its clear imaging. Overseas sales
rose in the first half of the year, led by Europe. In the second half of
the year, however, even medical institutions began curtailing new
investments amid the economic slowdown, resulting in lower sales
compared to the previous year. In addition, because a large portion
of sales of these products are generated in North America and
Europe, sales were greatly impacted by currency exchange rates.
Future Strategies
Under the basic strategy of strengthening communication with
doctors, we will establish specialized teams to develop new cus-
tomers in key regions, and further enhance collaboration among
development, production, and sales divisions and overseas sales
companies. We will also work to enhance product lineups to meet
the needs of university hospitals, clinics, and each region.
In terms of development, the Company is focused on develop-
ing products from the user’s perspective and uncovering latent
demand through constant, close contact with the medical commu-
nity. We will also actively participate in joint research with universi-
ties and companies in Japan and overseas.
Through these activities, we aim to increase total customer satis-
faction, from product development to sales and after-sales service.
Lifecare Business
The Pentax brand is recognized around world. Based on this brand, Hoya is making steady progress in uncovering new
possibilities for the future in the fields of cameras and medical devices.
PENTAX
21
HOYA Annual Report 2009